bullish
CanSino Biologics Placement: Liquidity Permits a Trade but Beware of COVID-19 Hype
437 Views06 Apr 2020 11:32
CanSino Biologics' shareholder Lilly Asia Venture is selling USD 76 million worth of stake in CanSino Biologics. In this insight, we will take a...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Related Insights
More »- CanSino Biologics (6185.HK/688185.CH) - From 2025 Onwards, Cansino Will Bring Decent Returns
- CanSino Biologics (6185.HK/688185.CH) - Breakeven May Arrive Earlier than Expected
- China Healthcare Weekly (Aug.11) - 2024 NRDL Negotiation, China Biotech Outlook, Bottom Fish CanSino
- CanSino Biologics (6185.HK/688185.CH) - 2024 Is the Best Time to Bottom-Fish This Stock
- CanSino Biologics (6185.HK/688185.CH) 23Q3 - Some Positive Business Progress Worth the Attention
Trending Collections
More »Trending Insights
More »- Hang Seng Indexes: FAF Methodology Change for Secondary Listings; Over US$1bn to Buy in NetEase
- [Japan Activism] - KKR and JIC Buy Out Topcon (7732 JP) At ¥3,300/Share
- Nikkei 225 Mar25 Rebal - A Big Buy With Buying Shadow, A Bigger Sell, And $2bn of Funding Flows
- Korea Short Selling: Off to the Races
- Ohayo Japan | Markets Rattled by Tariff Threats and Soaring Inflation Fears
Top Unpaywalled Insights
More »- Aiming for REITs with Lower Downside Risk and Expectations of Higher Shareholder Returns?
- Tariffs, Tapering, and Tectonic Shifts: Markets Brace for April | The New Barbarians #013
- APL Apollo Tubes (APAT IN) Stepping up the Gas on Capacity Expansions
- The LLM Quant Revolution: From ChatGPT to Wall Street
- The Fed's Next Move: How Interest Rates Will Make or Break Your Portfolio
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Wuxi Biologics Placement - Another One Before Lock-Up, but Just in Time for the Index Inclusion01 Sep 2020
- HSCI Index Rebalance - Stock Connect Flows Coming Up16 Aug 2020
- HSCI and Stock Connect - Biotech Stocks Now Eligible; Inclusion & Exclusion Possibilities21 Jul 2020
- CanSino Biologics Placement: Liquidity Permits a Trade but Beware of COVID-19 Hype06 Apr 2020
- CanSino Biologics (康希诺) IPO Trading Update - Time to Cash Out28 Mar 2019
- CanSino Biologics (康希诺) IPO: Valuation Attractive, Lilly Asia Doubling Up (Part 4)18 Mar 2019
x